Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells by Susan N Christo, Keely M McDonald, Thomas N Burn, Nadia Kurd, Jessica Stanfield, Megan M Kaneda, Ruth Seelige, Christopher P Dillon, Timothy S Fisher, Bas Baaten, Laura K Mackay

Get full text

Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy by Mithunah Krishnamoorthy, Mithunah Krishnamoorthy, Ruth Seelige, Christopher R. Brown, Nancy Chau, Natasja Nielsen Viller, Lisa D. S. Johnson, Emma Linderoth, Jean C. Y. Wang, Jean C. Y. Wang, Jean C. Y. Wang, Christopher P. Dillon, Keith Abayasiriwardana, Clare Lees, Mark Wong, Megan M. Kaneda, Robert A. Uger, Gloria H. Y. Lin, Gloria H. Y. Lin

Get full text